• RNASEH1-AS1 in Hepatocellular Carcinoma

  2026-09-21

  The reference study integrates TCGA bioinformatics, prognostic modeling, and cell-based validation to characterize RNASEH1-AS1 as a candidate diagnostic and prognostic biomarker in hepatocellular carcinoma. Its main contribution is linking elevated RNASEH1-AS1 to aggressive clinicopathological features, immune-infiltration patterns, a four-gene risk model, and DKC1-dependent RNA stability, while also providing evidence that RNASEH1-AS1 supports malignant cell behavior.

• Lipo3K Transfection Reagent for GBM Studies

  2026-09-21

  Discover how Lipo3K Transfection Reagent can support mechanistic glioblastoma studies of the PXDN–LDHA glycolytic axis. This article connects delivery design, rescue experiments, and metabolic assay controls to improve interpretation of gene perturbation data.

• Pioglitazone Workflows for PPARγ Research

  2026-09-20

  Build mechanism-focused metabolic and inflammatory assays with Pioglitazone, from macrophage polarization screens to DSS-induced intestinal inflammation studies. This guide combines product handling, translational workflow design, quantitative controls, and troubleshooting for more reproducible PPARγ agonist experiments.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

  2026-09-19

  Oliveira et al. show that naturally occurring angiotensin peptides can enhance SARS-CoV-2 spike binding to host receptors, with especially strong effects from N-terminally truncated peptides such as angiotensin IV. The work identifies peptide sequence and tyrosine modification as potential determinants of spike–receptor interaction, while also highlighting the need for cell-based and in vivo validation.

• NSP15 Screening Identifies Thymopentin and Oleuropein

  2026-09-18

  This 2021 study used structure-based virtual screening and molecular dynamics simulations to identify thymopentin and oleuropein as high-priority natural-product binders of SARS-CoV-2 NSP15. The work provides a hypothesis-generating framework for targeting viral RNA-processing and immune-evasion mechanisms, while its computational findings still require biochemical, cellular, and infection-model validation.

• Tranexamic Acid for Fibrinolysis Workflows

  2026-09-18

  Build more informative clot-stability, plasmin, and cell-adhesion experiments with Tranexamic Acid, an antifibrinolytic agent that connects molecular inhibition to biomaterial testing. This workflow emphasizes controlled concentrations, rapid solution handling, and factor-separated validation for wound-dressing and fibrinolysis research.

• GM 6001 (Galardin) for MMP Research

  2026-09-17

  GM 6001 (Galardin) provides broad MMP suppression for matrix-remodeling, migration, and signaling assays. This practical guide connects meniscal healing research, EGFR transactivation inhibition, cancer cell proliferation modulation, and vascular smooth muscle cell migration inhibition to reproducible workflows and troubleshooting decisions.

• From Caspase-8 Signals to Caspase-3 Strategy

  2026-09-17

  A translational framework for converting caspase-8 mechanistic findings into quantitative caspase-3 activity measurement, with strategic guidance for assay selection, validation, and therapeutic interpretation.

• Clathrin-Mediated Entry of Grass Carp Reovirus

  2026-09-16

  Wang et al. combined pharmacological inhibition, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a clathrin-, dynamin-, and endosome-acidification-dependent pathway. The study also found that Latrunculin B did not block infection under the tested conditions, making the result useful for distinguishing clathrin-mediated uptake from an essential requirement for actin filament assembly.

• Lambda Protein Phosphatase for BMAL1 Studies

  2026-09-16

  Lambda Protein Phosphatase provides a practical dephosphorylation strategy for testing how BMAL1 phosphorylation influences phase-separated transcriptional hubs. This guide connects λ-PPase assay design with antibody validation, phosphorylation site validation, and functional circadian readouts.

• Metabolic Stress, DNA Repair, and Repaglinide

  2026-09-15

  Energy availability is emerging as a controllable variable in genome maintenance. This thought-leadership analysis connects recent AML findings on ATG4B, PRMT1, and MRE11 with a translational strategy for evaluating Repaglinide as a hypothesis-generating metabolic perturbation—not as a validated leukemia therapy.

• SFI Inhibits Glioma via SRC/PI3K/AKT Signaling

  2026-09-15

  The reference study combines network pharmacology with cell-based and mouse experiments to investigate how Shenqi Fuzheng injection suppresses glioma proliferation and migration. Its results identify SRC/PI3K/AKT signaling as a candidate mechanistic axis, while also showing cell-cycle arrest, reduced epithelial–mesenchymal transition markers, and slower tumor growth in a transplanted model.

• S1P/S1PR3 Drives Neuronal Apoptosis After ICH

  2026-09-14

  The reference study identifies an S1P–S1PR3 axis that links acute intracerebral hemorrhage with CCL2 and TNF-α induction, PI3K/AKT-associated signaling, and caspase-3 activation in neurons. Mouse and HT22-cell experiments indicate that pharmacological S1PR3 blockade reduces apoptosis and improves injury-associated outcomes, while also emphasizing the receptor- and tissue-dependent nature of S1P biology.

• HNF4A-AS1 Loss Drives Sorafenib Resistance in HCC

  2026-09-14

  The 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its loss increases DECR1, reduces intracellular polyunsaturated fatty acids, and promotes drug resistance through an METTL3–m6A–YTHDF3 RNA regulatory axis.

• Tigecycline and the New MDR Research Playbook

  2026-09-13

  Tigecycline is more than a broad-spectrum glycylcycline antibiotic: it is a useful translational probe for connecting ribosomal inhibition, resistant-pathogen phenotypes, mobile carbapenemase genes, and clinically relevant infection models. This article outlines a surveillance-informed framework for evaluating its value in multidrug-resistant bacteria research.

8077 records 1/539 page Next 12345 下5页 Last page